These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 25648018)
21. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma. Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260 [TBL] [Abstract][Full Text] [Related]
22. Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma. Abdel-Aziz MM; Elshal MF; Abass AT; El-Kafrawy S; Ezzat S; Abdel-Wahab M Clin Lab; 2016; 62(6):1121-9. PubMed ID: 27468575 [TBL] [Abstract][Full Text] [Related]
23. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799 [TBL] [Abstract][Full Text] [Related]
24. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy. Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473 [TBL] [Abstract][Full Text] [Related]
25. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis. Worland T; Harrison B; Delmenico L; Dowling D J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172 [TBL] [Abstract][Full Text] [Related]
26. Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles. Huang KW; Yang SY; Hong YW; Chieh JJ; Yang CC; Horng HE; Wu CC; Hong CY; Yang HC Int J Nanomedicine; 2012; 7():1991-6. PubMed ID: 22619536 [TBL] [Abstract][Full Text] [Related]
27. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma. Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036 [TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma. Gao G; Dong F; Xu X; Hu A; Hu Y Int J Clin Exp Pathol; 2015; 8(9):11379-85. PubMed ID: 26617863 [TBL] [Abstract][Full Text] [Related]
29. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma]. Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741 [TBL] [Abstract][Full Text] [Related]
30. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma. Peng YC; Chan CS; Chen GH Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187 [TBL] [Abstract][Full Text] [Related]
31. Enzyme-linked immunosorbent assay for alpha-fetoprotein in human serum. Chui SH; Yow CM; Lam CW; Wan KC; Lewis WH Med Lab Sci; 1989 Oct; 46(4):305-8. PubMed ID: 2482399 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma. El-Abd N; Fawzy A; Elbaz T; Hamdy S Tumour Biol; 2016 Jan; 37(1):211-6. PubMed ID: 26189841 [TBL] [Abstract][Full Text] [Related]
33. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma. Yao M; Zhao J; Lu F Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252 [TBL] [Abstract][Full Text] [Related]
34. Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma. Gad A; Tanaka E; Matsumoto A; Wahab MA; Serwah Ael-H; Attia F; Ali K; Hassouba H; el-Deeb Ael-R; Ichijyo T; Umemura T; Muto H; Yoshizawa K; Kiyosawa K World J Gastroenterol; 2005 Nov; 11(42):6607-12. PubMed ID: 16425352 [TBL] [Abstract][Full Text] [Related]
35. Establishment of assay kits for the determination of microheterogeneities of alpha-fetoprotein using lectin-affinity electrophoresis. Shimizu K; Taniichi T; Satomura S; Matsuura S; Taga H; Taketa K Clin Chim Acta; 1993 Jan; 214(1):3-12. PubMed ID: 7680970 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma. Hu J; Wang N; Yang Y; Ma L; Han R; Zhang W; Yan C; Zheng Y; Wang X BMC Gastroenterol; 2018 Dec; 18(1):186. PubMed ID: 30545306 [TBL] [Abstract][Full Text] [Related]
37. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma. Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578 [TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. Tangkijvanich P; Anukulkarnkusol N; Suwangool P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y J Clin Gastroenterol; 2000 Dec; 31(4):302-8. PubMed ID: 11129271 [TBL] [Abstract][Full Text] [Related]
39. Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone. Erdal H; Gül Utku Ö; Karatay E; Çelik B; Elbeg Ş; Doğan İ Turk J Gastroenterol; 2016 Jul; 27(4):375-81. PubMed ID: 27458854 [TBL] [Abstract][Full Text] [Related]
40. Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein. Korekane H; Hasegawa T; Matsumoto A; Kinoshita N; Miyoshi E; Taniguchi N Biochim Biophys Acta; 2012 Sep; 1820(9):1405-11. PubMed ID: 22233759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]